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Abstract
Background: Carriers of apparently balanced translocations are usually phenotypically normal; however in about 6% of
de novo cases, an abnormal phenotype is present. In the current study we investigated 12 patients, six de novo and six
familial, with apparently balanced translocations and mental retardation and/or congenital malformations by applying 1
Mb resolution array-CGH. In all de novo cases, only the patient was a carrier of the translocation and had abnormal
phenotype. In five out of the six familial cases, the phenotype of the patient was abnormal, although the karyotype
appeared identical to other phenotypically normal carriers of the family. In the sixth familial case, all carriers of the
translocations had an abnormal phenotype.
Results: Chromosomal and FISH analyses suggested that the rearrangements were "truly balanced" in all patients.
However, array-CGH, revealed cryptic imbalances in three cases (3/12, 25%), two de novo (2/12, 33.3%) and one familial
(1/12, 16.6%). The nature and type of abnormalities differed among the cases. In the first case, what was identified as a
de novo t(9;15)(q31;q26.1), a complex rearrangement was revealed involving a ~6.1 Mb duplication on the long arm of
chromosome 9, an ~10 Mb deletion and an inversion both on the long arm of chromosome 15. These imbalances were
located near the translocation breakpoints. In the second case of a de novo t(4;9)(q25;q21.2), an ~6.6 Mb deletion was
identified on the short arm of chromosome 7 which is unrelated to the translocation. In the third case, of a familial,
t(4;7)(q13.3;p15.3), two deletions of ~4.3 Mb and ~2.3 Mb were found, each at one of the two translocation breakpoints.
In the remaining cases the translocations appeared balanced at 1 Mb resolution.
Conclusion: This study investigated both de novo and familial apparently balanced translocations unlike other relatively
large studies which are mainly focused on de novo cases. This study provides additional evidence that cryptic genomic
imbalances are common in patients with abnormal phenotype and "apparently balanced" translocations not only in de
novo but can also occur in familial cases. The use of microarrays with higher resolution such as oligo-arrays may reveal
that the frequency of cryptic genomic imbalances among these patients is higher.
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Background
The great majority of cases with apparently balanced
translocations are usually not associated with abnormal
phenotypes. Apparently balanced rearrangements in gen-
eral, represent an interpretational and counseling
dilemma when detected in cases with abnormal pheno-
types and/or mental retardation.
The risk for phenotypic abnormalities differs between de
novo and familial balanced translocations. Warburton et
al., 1991 [1] estimated the risk in carriers of de novo recip-
rocal translocations detected at prenatal diagnosis to be
6,1%, while Madan et al., 1997 [2] in a subsequent review
of 60 cases revealed that the risk is even higher when the
translocation is complex, as 14/27 of the complex cases
were associated with multiple congenital anomalies and/
or mental retardation.
In familial cases, the increased risk lies mainly in the pro-
duction of abnormal gametes which leads to multiple
miscarriages or to the birth of a child with congenital
abnormalities. If the same balanced rearrangement as in
the carrier parent is detected at prenatal diagnosis, the risk
for phenotypic abnormality in the offspring is believed to
be very low. However, there are several studies that report
patients with abnormal phenotype and the same balanced
rearrangement as their phenotypically normal carrier par-
ent [3-5].
Several mechanisms were proposed to explain the clinical
phenotype in both de novo and familial balanced translo-
cations, which includes :i) disruption of a dosage-sensi-
tive gene at the breakpoints or expression a recessive gene
[6], ii) position effect with variable expression of genes
near the translocation breakpoint [7] iii) uniparental dis-
omy (if the chromosome involved is subjected to imprint-
ing) due to post-conceptional "correcting" loss of the
homolog from the normal non-carrier parent [8] iv) the
rearrangement is not truly balanced at the DNA level or in
familial cases may be additional unbalanced subtle rear-
rangements occurred during meiosis [9] v) the rearrange-
ment may host 'cryptic' complex chromosomal
rearrangements (CCRs)[10].
One of the first studies that investigated the possibility
that apparently balanced translocations may in fact be
CCRs was carried out by our group in 2004 [10] and 20
families (18 inherited and 2 de novo) were analyzed. The
above study detected CCRs in 3 out of the 20 families
studied and suggested that the link between an apparently
balanced rearrangement and the appearance of abnormal
phenotype may be partly explained by the presence of
cryptic complex chromosomal rearrangements and that
more breaks may lead to imbalances. The above study was
based only on FISH approaches and therefore small inter-
stitial rearrangements/imbalances may have been missed.
The development of the array-based comparative genomic
hybridization (array-CGH) overcame the limitations of
both cytogenetic and FISH approaches and provided the
opportunity to screen the entire genome for cryptic
genomic gains and losses [5,11,12].
A high level of unexpected rearrangement complexity,
including deletions, inversions and insertions at or near
one or both breakpoints as well as imbalances on chro-
mosomes unrelated to the translocations were found by
Gribble et al., 2005 [13] in their systematic analysis of
constitutional de novo apparently balanced carriers. Imbal-
ances were detected in 6/10 (60%) of the patients studied.
Most of the recent relatively large studies are however
focused on de novo balanced translocations [13,14]. In the
current study, we report 12 cases, six de novo and six famil-
ial, of apparently two-way balanced translocations in
patients with mental retardation and congenital malfor-
mations that were investigated by 1 Mb array-CGH. In the
familial cases the patients had an abnormal phenotype
but their karyotype appeared identical to other phenotyp-
ically normal translocation carriers of the family. In one
familial case all the carriers of the translocations had
abnormal phenotype.
Results
Array-CGH revealed cryptic genomic imbalances in three
cases out of the twelve cases studied (25%), two out of the
six de novo (33.3%) and one out of the six familial cases
(16.6%). Summarized results of all the aberrations
detected by array-CGH are shown in table 1. The imbal-
ances detected by array-CGH among the de novo cases
Table 1: shows the abnormalities detected by array-CGH.
Case Initial Karyotype Imbalances (array-CGH) Size
1 46,XY,t(9;15)(q31;q26.1)de novo dup(9)(q34.1q34.3) ~6.1 Mb
del(15)-complex ~10 Mb
inv(15)(q21.1q22.3) ~3 Mb
2 46,XY,t(4;9)(q25;q21.2)de novo del(7)(p12.3p13) ~6.6 Mb
3 46,XX,t(4;7)(q13.3;p15.3)mat del(4)(q13.3q13.3) ~4.3 Mb
del(7)(p15.3p21.1) ~2.3 MbMolecular Cytogenetics 2008, 1:15 http://www.molecularcytogenetics.org/content/1/1/15
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were not found in their chromosomally and phenotypi-
cally normal parents thus excluding polymorphism.
In five out of the six familial cases the patients of each
family had an abnormal phenotype but their karyotype
appeared identical to other phenotypically normal trans-
location carriers of the family. No imbalances were
detected in these five cases and the translocation appeared
balanced at 1 Mb resolution.
In one of the six familial cases, all the carriers of the trans-
locations in the family including the patient's mother and
sister shared the same abnormal phenotype. Array-CGH
revealed the same imbalances that were initially detected
in the older daughter, in her mother and sister.
Case 1: 46,XY,t(9;15)(q31;q26.1)de novo
The above patient is a 2-year-old boy with a peculiar facies
and psychomotor retardation, especially gross motor
retardation and speech delay. His weight is 11.700 gr (25th
centile), the height 86 cm (50th centile), and the head cir-
cumference 49 cm (75th centile). He was born by a caesar-
ean section at 35 weeks' gestation with a small weight for
gestational age (1.880 gr, <3rd centile). As an infant the
patient presented hypotonia in association with severe
recurrent episodes of apnea, bradycardia and cyanosis,
almost on a daily base. Patient's dysmorphic features
include frontal bossing with narrow biparietal diameter,
prominent eyes with blue sclerae, broad nasal bridge, low
set ears, high narrow palate, retrognathia, upsweep of
frontal scalp hair, abnormal palmar creases, bilateral over-
lapping toes, and omphalocele. In addition, the patient
has gastro-esophageal reflux, a small atrial septal defect,
and a right renal rotation around its elongated axis.
Chromosomal and FISH [subtelomeric and whole chro-
mosome paint (wcp)] analyses of this patient showed an
apparently balanced de novo translocation between chro-
mosomes 9 and 15. The initial karyotype was designated
as 46,XY,t(9;15)(q31;q26.1)dn. Array-CGH though
revealed an ~6.1 Mb duplication on chromosome 9 at
9q34.2-q34.3 and deletions on three regions of chromo-
some 15 adding to ~10 Mb (Figure 1). A fourth region also
appeared deleted on chromosome 15 but FISH analysis
using the corresponding BAC clone showed normal sig-
nals. The imbalances detected by array-CGH were on the
same chromosomes involved in the translocation but not
directly associated with them. The array-CGH findings
were confirmed using FISH with 14 region-specific BAC
clones. During confirmation of the array findings, the
rearrangement was found to be even more complex with
additional breakpoints (at least 5 breakpoints) and an
inversion was unexpectedly identified involving chromo-
some 15 with breakpoints at q21.1 and q21.2. FISH using
the same BAC clones was also performed for the parents
of the patients and normal results were obtained.
Revised karyotype after FISH confirmation of the array
results:
46,XY,t(9;15)(q31;q26.1).ish
dup(9)(q34.1q34.3)(RP11-295G24++, RP11-
417A4++),del(15)(q21.2q21.3)(RP11-32N2-
),del(15)(q22.31q23)(RP11-321F6-, RP11-540N15-,
RP11-375D9-),del(15)(q25.1q25.2)(RP11-2E17-),
inv(15)(q21.1q21.2)(RP11-90J19st,RP11-
353B9mv,RP11-105D1mv, RP11-313P18mv)dn.
Case 2: 46,XY,t(4;9)(q25;q21.2)de novo
The patient, a 22 years old male, has a history of mild
mental and growth retardation, motor dyspraxia and
myoclonic seizures. He presents antimongoloid palpebral
fissures, microtia, high-arched palate, low-set and dys-
plastic ears, strabismus, bulbous nose, short webbed neck,
low posterior hairline, scoliosis, lordosis, short nails and
broad first toes bilaterally.
Chromosomal and FISH (subtelomeric and wcp) analyses
of this patient showed an apparently balanced de novo
translocation between chromosomes 4 and 9. The initial
karyotype was designated as 46,XY,t(4;9)(q25;q21.2)dn.
Array-CGH however showed an ~6.6 Mb deletion on
chromosome 7 which is unrelated to the translocation
(Figure 2). The above findings were confirmed using FISH
with 6 region-specific BAC clones.
Revised karyotype after FISH confirmation of the array
results:
46,XY,t(4;9)(q25;q21.2).ish del(7)(p12.3p13)(RP4-
815D20-,RP11-52M17,RP11-36H20-)dn.
Case 3: 46,XX,t(4;7)(q13.3;p15.3)mat
Case 3 involves a familial translocation between chromo-
somes 4 and 7 which was inherited from the mother. The
above family has 3 children, two daughters that are both
carriers of the translocation and share the same clinical
phenotype and one son with normal karyotype and phe-
notype. The older daughter is currently 16 years old and
the younger is 15. They were both born after uneventful
pregnancies and deliveries. As infants, they had feeding
problems and delayed motor milestones. They both have
moderate mental retardation, seizures, attention deficit
hyperactivity syndrome and severe learning difficulties.
They attend school for children with special needs. They
have no dysmorphic features or other congenital abnor-
malities. The mother has also mental retardation but in
milder form.Molecular Cytogenetics 2008, 1:15 http://www.molecularcytogenetics.org/content/1/1/15
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Chromosomal and FISH (subtelomeric and wcp probes)
analyses of the mother and her daughters revealed appar-
ently identical karyotypes: 46,XX,t(4;7)(q13.3;p15.3).
Array-CGH revealed an ~4.3 Mb and an ~2.3 Mb deletion
on chromosome 4 and 7, respectively in all carriers (Fig-
ure 3). These copy number changes were located at the
breakpoints of the translocations and were confirmed
with 6 region-specific BAC clones.
Revised karyotype after FISH confirmation of the array
results:
Array-CGH results of case 1 for chromosomes 9 and 15, schematic comparison of the array and FISH findings and partial kary- otypes Figure 1
Array-CGH results of case 1 for chromosomes 9 and 15, schematic comparison of the array and FISH findings and partial kary-
otypes.Molecular Cytogenetics 2008, 1:15 http://www.molecularcytogenetics.org/content/1/1/15
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46,XX,t(4;7)(q13.3;p15.3).ish del(4)(q13.3q13.3)(RP11-
373J21-), del(7)(p15.3p21.1)(RP11-445O1-,RP11-
47E14-)mat.
Discussion
Array-CGH revealed cryptic genomic imbalances at 1 Mb
resolution in three out of the twelve cases studied (25%)
with an apparently balanced translocation and abnormal
phenotype, in two of the six de novo cases (33.3%) and in
one of the six familial cases (16.6%). The remaining of the
cases appeared to be simple and balanced at 1 Mb resolu-
tion.
The present study is to our knowledge the first where a rel-
atively large number of patients with familial balanced
translocations and abnormal phenotype were investigated
for cryptic imbalances using array-CGH, unlike most of
the studies that are focused on de novo cases. Usually,
familial cases are reported as individual case studies. Only
one other study has been performed with array-CGH by
[5]Ciccone et al.,2005 in four cases, two de novo and two
Array-CGH results of case 2 for chromosome 7 and schematic comparison of the array and FISH findings and partial karyo- types Figure 2
Array-CGH results of case 2 for chromosome 7 and schematic comparison of the array and FISH findings and partial karyo-
types.Molecular Cytogenetics 2008, 1:15 http://www.molecularcytogenetics.org/content/1/1/15
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familial of patients with balanced translocations and
abnormal phenotype.
The frequency of imbalances detected in the de novo cases
is in accordance with the largest systematic study per-
formed to date by De Gregori et al 2007 [14], where 27
apparently balanced de novo translocations with abnor-
mal clinical phenotype were analyzed with high density
(20 kb or 100 kb resolution) oligo array-CGH and 11
cases with copy number imbalances (40.7%) were
detected. Another study by Gribble et al, 2005, [13] using
1 Mb resolution array-CGH, detected imbalances in 6 out
of 10 (60%) of the de novo balanced translocation cases
with abnormal phenotype. Although the sample sizes are
Array-CGH results of case 3 for chromosomes 4 and 7 and schematic comparison of the array and FISH findings and partial  karyotypes Figure 3
Array-CGH results of case 3 for chromosomes 4 and 7 and schematic comparison of the array and FISH findings and partial 
karyotypes.Molecular Cytogenetics 2008, 1:15 http://www.molecularcytogenetics.org/content/1/1/15
Page 7 of 9
(page number not for citation purposes)
still small, we can safely assume by combining the two
previous studies with the supporting evidence of the cur-
rent study that about 30–50% of the de novo apparently
balanced translocations with abnormal phenotype are
associated with causative cryptic imbalances. In the
remaining 50–70% of the patients the phenotype might
me caused by other mechanisms such as interruption of a
dosage sensitive gene, or by uniparental disomy or by
unmasking of a recessive mutated gene on the homolog
chromosome or finally by position effect with variable
expression of a gene(s) near the translocation breakpoint.
However a disruption of a recessive gene might occur at
the breakpoints of the translocation without a phenotypic
effect. Baptista et al., 2008 [15] studied 31 cases of bal-
anced translocation carriers with normal phenotype using
FISH to refine the breakpoints and 1 Mb array-CGH to
detect imbalances. In this study no cryptic imbalanced
were detected in individuals with normal phenotype but
interruption of genes was detected in 16 of the 31 individ-
uals studied.
Only in one case (Case 3), out of the six familial cases ana-
lyzed, additional aberrations were identified, which
involved a family where all translocation carriers shared
the same abnormal phenotype. The deletions detected at
the breakpoints of the translocation were present in all
carrier family members and absent in the phenotypically
normal members of the family. In the remaining five fam-
ilies in which only the patients had an abnormal pheno-
type while all the other carriers were phenotypically
normal no additional aberrations were detected at the res-
olution of 1 Mb. Results obtained in the current study
from the familial cases suggest that cryptic copy number
changes at least at the resolution of 1 Mb, do not consti-
tute a major cause for the phenotypic abnormalities in
patients with familial apparently balanced translocations.
However, the study by Ciccone et al 2005 [5], revealed
cryptic imbalances in one de novo case and in both
patients with familial translocations suggesting that cryp-
tic imbalances in familial cases may be common. There-
fore more familial cases need to be analyzed in order to
draw final conclusions. It is possible that higher resolu-
tion arrays such as high-density oligo-arrays may reveal
smaller aberration that could have been missed in the cur-
rent study due to lower resolution. It is also possible, that
other mechanism are involved in inherited cases like pro-
duction of a recessive mutation by the translocation that
is expressed when a mutation in the same gene is inher-
ited from the other parent or the phenotype might simply
be coincidental and unrelated to the translocation.
It is interesting that in a study published by our group in
2004 [10], in which balanced translocations were investi-
gated for the presence of cryptic complex rearrangements,
case 3 was then was classified as simple since only FISH
approaches were used. As a result the imbalances detected
here by array-CGH were missed. This demonstrates the
value of array-CGH for the detection of cryptic subtle rear-
rangements. However, it is also important to point out
that confirmation of array-CGH results with FISH studies
is always necessary, as it was illustrated in Case1 of the
present study, where during FISH confirmation, an inver-
sion was unexpectedly revealed.
The nature, location and size of the abnormalities differed
among the three cases. Among the imbalances detected
three were deletions, one was a duplication and one an
inversion and their size ranged from 2.3 to 10 Mb. The
locations of these rearrangements relative to the transloca-
tion breakpoints were also different from case to case. In
the first case, the imbalances were on the same chromo-
somes involved in the translocation but were not directly
associated with the breakpoints, in the second case a dele-
tion was identified on a chromosome, unrelated to the
translocation and in the third case imbalances were found
at the translocation breakpoints. The above results show
that cryptic aberrations are not always related to the rear-
rangements breakpoints. Similar results were previously
reported by other studies [5,13,14].
Balanced translocations remain a challenge for geneticists
especially when they are detected prenatally. In the case of
familial translocations, the translocation present in the
parent should always be investigated with FISH assays to
determine whether it is a simple two way translocation or
it involves more chromosomes so that more accurate diag-
nosis in the fetus is performed. In de novo cases, it should
also be investigated with FISH assays since more breaks
usually involve higher risk. In addition, in cases of de novo
translocations, array-CGH should be performed as subtle
copy number changes may be present not only at the
breakpoints but anywhere else in the genome. Although,
array-CGH is well established method and is widely used
for the evaluation of patients with mental retardation and
congenital abnormalities, its implementation in prenatal
diagnosis is still very limited. A major factor for the lim-
ited used of array-CGH in prenatal diagnosis is the pres-
ence of benign copy number variations (CNVs) [16,17]
which can extend up to several Mb and may cause prob-
lems in result interpretation. However, as new publica-
tions and databases with CNV data emerge, array CGH
will be incorporated in the methodologies used in prena-
tal diagnosis, especially in cases with normal or "balanced
karyotypes" and ultrasound abnormalities.
Conclusion
The current study provides additional evidence and con-
firms previous studies which showed that cryptic genomic
imbalances are common (33.3%) in patients with abnor-
mal phenotype and de novo "apparently balanced" trans-Molecular Cytogenetics 2008, 1:15 http://www.molecularcytogenetics.org/content/1/1/15
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locations. In contrast to previous investigations both de
novo (six cases) and familial (six cases) cases were ana-
lyzed by array-CGH and imbalances were identified in
both de novo and familial cases. These imbalances were
either linked (near or at the breakpoints of the transloca-
tion) or were unrelated to the rearrangement. These find-
ings further highlight the necessity of whole genome
approaches for "apparently balanced" rearrangements.
Methods
Patients
Twelve patients with apparently balanced translocations
familial or de novo and abnormal clinical phenotype were
included in the study. In all de novo cases, only one mem-
ber of each family was a carrier of a translocation and had
an abnormal phenotype while all the other members had
normal karyotypes and normal phenotypes. In five out of
the six familial cases the patients of each family had an
abnormal phenotype but their karyotype appeared identi-
cal to other phenotypically normal translocation carriers
of the family. In one familial case, all the carriers of the
translocations had abnormal phenotype.
Family history and clinical information of each patient
were recorded. Patients were included in the study only if
chromosomal and FISH analyses suggested that the rear-
rangement was "truly" balanced.
Chromosomal and FISH Studies
Chromosomal analyses were performed from peripheral
blood samples using conventional GTG-banding tech-
niques at the 550-band level.
FISH analyses were performed using commercially availa-
ble subtelomeric specific probes and whole chromosome
paints (wcp) to confirm that the translocations were "truly
balanced". FISH procedures were performed according to
the manufacturer's protocols (VYSIS. Inc, USA).
FISH was also carried out using BAC-probes for confirma-
tions of the array-CGH findings. Location of the clones
was obtained from NCBI http://www.ncbi.nlm.nih.gov.
Labelling and FISH procedures were performed according
to the manufacturer's protocols (VYSIS. Inc, USA)
Array-CGH
DNA was isolated using the PUREGENE DNA extraction
kit (Gentra, USA) according to the supplier's protocol. The
Cytochip 1-Mb resolution chip (BlueGnome, Cambridge,
UK) was used for microarray-CGH analysis. Array-CGH
was carried out according to the recommendations of the
manufacturer. In brief, DNAs were labelled by random
priming using Bio Prime labelling kit (Invitrogen, UK)
with cyanine 3 and cyanine 5 (Amersham Biosciences,
UK) fluorescent dyes. DNAs were co-hybridized on two
microarrays as dye swap was used. Pooled genomic DNA
from Promega (UK) was used as reference. Data was ana-
lysed with the BlueFuse for microarrays software package
(BlueGnome, Cambridge, UK).
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